Sprucegrove Investment Management’s Pfizer PFE Stock Holding History

Sprucegrove Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-949	Closed	-$30.8K	–	58
2017 Q1	$30.8K	Hold	949	–	–	﹤0.01%	57
2016 Q4	$29K	Sell	949 -9,043	-91%	-$276K	﹤0.01%	58
2016 Q3	$321K	Sell	9,992 -361,975	-97%	-$12.1M	0.01%	58
2016 Q2	$12.4M	Sell	371,967 -186,031	-33%	-$5.94M	0.51%	46
2016 Q1	$15.7M	Sell	557,998 -858,751	-61%	-$24.5M	0.63%	42
2015 Q4	$43.4M	Sell	1,416,749 -574,472	-29%	-$18.1M	1.23%	31
2015 Q3	$59.3M	Sell	1,991,221 -155,887	-7%	-$5M	1.48%	25
2015 Q2	$68.3M	Sell	2,147,108 -140,933	-6%	-$4.59M	1.46%	30
2015 Q1	$75.5M	Sell	2,288,041 -2,539,346	-53%	-$80.7M	1.51%	26
2014 Q4	$143M	Sell	4,827,387 -124,915	-3%	-$3.58M	2.63%	15
2014 Q3	$139M	Sell	4,952,302 -154,965	-3%	-$4.35M	2.48%	19
2014 Q2	$144M	Sell	5,107,267 -44,735	-0.9%	-$1.28M	2.44%	19
2014 Q1	$157M	Sell	5,152,002 -234,962	-4%	-$7.01M	2.74%	13
2013 Q4	$157M	Sell	5,386,964 -261,024	-5%	-$7.6M	2.69%	17
2013 Q3	$154M	Sell	5,647,988 -733,710	-11%	-$20M	2.79%	15
2013 Q2	$170M	Buy	+6,381,698	New	+$176M	3.08%	13

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sprucegrove Investment Management's PFE Position: Q2 2017 in Review

Sprucegrove Investment Management sold out of Pfizer (PFE) in Q2 2017, closing a stake of 949 shares — an estimated $30.8K sold.

Sprucegrove Investment Management first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $170M in Q2 2013. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Sprucegrove Investment Management reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
Sprucegrove Investment Management sold 949 Pfizer shares in Q2 2017, an estimated $30.8K.
Sprucegrove Investment Management first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
Sprucegrove Investment Management's Pfizer position peaked at $170M in Q2 2013.
2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Sprucegrove Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.